menu ☰
menu ˟

FDA reports suggest antidepressant efficacy of ketamine

09 May 2017
Analysis of population-level data suggested significant efficacy of ketamine for depression and pain. “Current FDA-approved treatments for depression fail for millions of people because they don't work or don’t work fast enough,” study research...

Click here to view the full article which appeared in Psychiatry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.